Philips to Acquire Capsule Technologies Inc.

Royal Philips has signed an agreement to acquire Capsule Technologies Inc., a provider of medical device integration and data technologies for hospitals and healthcare organizations.

HealthMyne Appoints National Oncology Leader to Board of Directors

HealthMyne, a pioneer in applied radiomics, has announced the appointment of Mimi Huizinga, MD, MPH, FACP, to its board of directors.

MITA Applauds CMS for Creation of Medicare Coverage Pathway for Innovative Medical Technologies

The Medical Imaging & Technology Alliance (MITA), the leading organization and collective voice of medical imaging equipment, radiopharmaceutical, contrast media, and focused ultrasound device manufacturers, today applauded the Centers for Medicare & Medicaid Services (CMS) for its recently issued final rule concerning the Medicare Coverage of Innovative Technology (MCIT) program.

KA Imaging Appoints Seasoned Industry Executives to Key Leadership Positions

Manufacturer KA Imaging has appointed Shawn Campbell as vice president of operations and Robert Moccia as vice president of sales, USA and Canada.

People on the Move – July 8, 2019

By Matt Skoufalos

Laura Slatkin

Cold Spring Harbor Laboratory (CSHL) of Cold Spring Harbor, New York added Laura Slatkin to its board of trustees. Slatkin is the founder of fragrance company Slatkin & Co., the nonprofit NEXT for AUTISM, is a founding board member of Autism Speaks, for which she served on the board of directors for 13 years. Slatkin also sits on the boards of the Columbia University Department of Psychiatry, the Hunter College Autism Research and Policy Board, and the Henry Street Settlement House.


Endeavors of San Antonio, Texas named Adriana Wilson its Deputy Development Officer. Previously, Wilson was its director of business development; she has also been business development manager at United Medevac Solutions.


The Torrance, California-based Emmaus Life Sciences named Michael Schwarz product manager for its sickle-cell treatment, Endari.  Schwarz has spent 15 years in the commercialization of specialty medicines and other therapies for treating rare diseases, and joins the company from Novartis Pharmaceuticals, where he was responsible for supporting its hematology, HIV, and HBV franchises.


Caris Life Sciences of Irving, Texas named Steven D. Averbuch to its scientific advisory board. Averbuch is the former VP and head of precision medicine in the translational medicine division of R&D at Bristol-Myers Squibb. He has also held leadership roles at Merck Research Laboratories and at AstraZeneca, and once held academic appointments at Mount Sinai School of Medicine and the U.S. Public Health Service (USPHS) School of Medicine. Averbuch also sits on boards and committees for the Personalized Medicine Coalition, the National Biomarker Development Alliance, and the University of Kansas Institute for Advancing Medical Innovation.


Brookdale Senior Living Inc. of Nashville, Tennessee will see 10-year director James R. Seward not stand for re-election. Seward previously chaired the company’s investment committee.


Inari Medical, Inc. of Irvine, California named Thomas M. Tu its Chief Medical Officer. Tu previously chaired the Emerging Leader Mentorship program, a joint venture among the Society for Cardiovascular Angiography and Interventions (SCAI), the American College of Cardiology, and the Cardiovascular Research Foundation. He is also the former chairman of the SCAI political action committee (SCAI-PAC). Tu is board-certified in cardiology, interventional cardiology, and is fellowship-trained in peripheral vascular intervention.


Dr. Cabana, Physician-in-Chief, Children’s Hospital at Montefiore

The New York, New York-based Montefiore Health System and Albert Einstein College of Medicine today named Michael deCastro Cabana Physician-in-Chief at Children’s Hospital at Montefiore (CHAM) and University Chair of Pediatrics at Montefiore and Einstein. Cabana is currently a professor of pediatrics and epidemiology and biostatistics at the University of California, San Francisco (UCSF), where he also is Chief of General Pediatrics and teaches at the Philip R. Lee Institute for Health Policy Studies. He will join Montefiore and Einstein September 9.


The Naples, Florida-based Guest Services Senior Living named Shawn Rose its VP of Operations. Rose has nearly 20 years of experience in the senior care industry; prior to joining the company, he was regional director of operations for Senior Lifestyle Corporation. Rose has also been SVP of sales and marketing for Raydian Properties, and has worked with Capital Senior Living, Emeritus Senior Living, and Brandywine Senior Living.


Medicomp Systems CEO David Lareau has been named to the invite-only Forbes Technology Council community for CIOs, CTOs, and technology executives. As a member of the council, Lareau will contribute to and roundtable discussions hosted by the council.


The Pancreatic Cancer Action Network (PanCAN) of Manhattan Beach, California, named Andrew Lowy, professor of surgery and Chief of Surgical Oncology at the University of California San Diego School of Medicine, to chair its Scientific and Medical Advisory Board (SMAB).  Margaret A. Tempero, director of the UCSF pancreas center and professor of medicine at the University of California, San Francisco, is the new chair-elect. Lowy joined the board in 2016 and served as chair-elect for the past two years. Tempero has been with the board since the founding of PanCAN in 1999.


Celeste Ortiz of Crossover Health joins SCAN Health Plan board of directors

Brandon Jones of Google Cloud joins SCAN Health Plan board of directors

SCAN Health Plan of Long Beach, California named Celeste Ortiz, chief people officer of Crossover Health, and Brandon Jones, head of Americas sales development at Google Cloud, to its board of directors. Ortiz has 20 years of human resources experience at Medtronic, Johnson & Johnson, and Pfizer Pharmaceuticals.

Jones previously led the U.S. product operations team for seven Google technology products, and has spent nearly a decade at Bank of America, Merrill Lynch, Johnson & Johnson, and Marsh & McLennan.


Steven M. Safyer

Montefiore Medicine president and CEO Steven M. Safyer will step down from his position atop the organization after more than a decade. Safyer rose through the ranks at the health system, having been its SVP, president, and Chief Medical Officer from 1998 to 2008, when he was named president and CEO. Under his leadership, Montefiore grew to become an 11-hospital network with more than 200 ambulatory care centers. Safyer will remain with the institution until a replacement is named.





Submit a Comment

Your email address will not be published. Required fields are marked *